6505-17-113-6166
Zidovudine Tablet
6505171136166 171136166 13710300 RE286405
Managed by Netherlands
NSN Created on 19 Oct 2000
Data Last Changed
November 2023
November 2023
NATO Update Count
1
1
NATO Data Quality
Marketplace 6505-17-113-6166
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-17-113-6166 4+ Documents (More...)
25MG100STRNCC: 3 | RNVC: 2 | DAC: 6LAN0XINTAB0-25MG100STRNCC: 3 | RNVC: 2 | DAC: 6 17 Jun 1972 6505-17-113-6166
(CAGE Code H6461) 17 Jun 1972 6505-17-113-6166 Zidovudine Tablet 13710300RNCC: 3 | RNVC: 2 | DAC: 4 19
Lidocaine Hydrochloride Injection,Modified 10 Items Stock Items From Supply Class 6505 Page 1 of 4 6505-17-113-6166
Nov 1999 6505-17-112-2609 Lidocaine En Adrena XY088303RNCC: 3 | RNVC: 2 | DAC: 3 6 Nov 1998 6505-17-113-6166
Restrictions 6505-17-113-6166
End Users 6505-17-113-6166
- Netherlands (ZN)
Approved Sources 6505-17-113-6166
- Part Number
- Manufacturer
- Status
- 13710300
- Manufacturer
- H6461 - Glaxo Wellcome International B.V. (Obsolete)
- Primary Buy
- Primary Buy
- RE286405
- H5841 - Brocacef B.V. (Active)
- Secondary Buy
- Secondary Buy
NATO Stock Numbers Related to 6505-17-113-6166
2510-15-209-3009 2520-99-446-6108 6220-15-204-1528 9999-37-515-0085 5310-15-139-2426 9915-15-219-4601 1730-25-105-4112 1220-14-266-0252 4030-15-175-3668 6685-14-380-3542 1560-99-601-1385 1680-99-600-3219 1005-13-103-5661 2540-15-138-4766 4920-14-441-3681 5340-14-436-9248 2910-12-148-8383 5820-15-138-1601